A phase I/II and pharmacokinetic study of irrinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.

Translated title of the contribution: A phase I/II and pharmacokinetic study of irrinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.

D. Rea, JW Nortier, W.W. Ten Bokkel-Huinink, S. Falk, D.J. Richel, T. Maughan, G. Groenewegen, J.M. Smit, N. Steven, J.M. Bakker, D. Semiond, DJ. Kerr, C.J Punt

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionA phase I/II and pharmacokinetic study of irrinotecan in combination with capecitabine as first-line therapy for advanced colorectal cancer.
Original languageUndefined/Unknown
Pages (from-to)1123-1132
Number of pages10
JournalAnnals of Oncology
Volume16
Issue number7
Publication statusPublished - 2005

Cite this